CPMP recommends approval of Ligand's Targretin

The EMEA's Committee for Proprietary Medicinal Products (CPMP) recommended approval of LGND's Targretin bexarotene capsules to treat advanced stage cutaneous T cell lymphoma (CTCL) refractory to at le...